A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Clinical trial NCT07149857 · RECRUITING

Trial details

NCT number: NCT07149857
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2025-10-03
Primary completion: 2028-04-12
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.